Genome Medical
PrivateLast Round
Series D
Sep 1, 2024
Est. Valuation
$39M
Total Funding Raised
$195.34M
Company Overview
Genome Medical is a digital health company that provides telehealth-enabled genetic counseling and genomic medicine services to individuals, healthcare providers, and health systems.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Precision Medicine, Clinical Trials, Patient Engagement
Business Model
B2B2C
Customer Profile
Services & Consulting, Subscription SaaS, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genome Medical Comparables
Compare Genome Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| InformedDNA | 85% | |
| Metis Genetics | 82% | |
| DNAvisit | 81% | |
Genome Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Sep 1, 2024 | ||||
| Series C | Aug 30, 2021 | ||||
| Series B Extension | Jul 1, 2020 | ||||
| Series B | Jun 11, 2019 | ||||
| Series A Extension | Jan 5, 2018 | ||||
Series A | May 25, 2017 |
Key People
Founding team and executive leadership
Genome Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GV | Series C |
| Perceptive Advisors | Series C, Series B Extension, Series B |
| Kaiser Permanente Ventures | Series C, Series B Extension, Series B, Series A Extension |
| Manatt Ventures | Series B, Series B Extension |
| Avestria Ventures | Series C, Series B Extension |
| Dreamers VC | Series C, Series B Extension |
| Amgen Ventures | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 3, 2025
Recognized as one of the Top 50 in Digital Health.
- Jan 17, 2025
Partnered with Nest Genomics to expand genetic services access.
Genome Medical Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Genome Medical's valuation, stock price, and market status.